Indonesia · Delayed Price · Currency is IDR Revance Therapeutics Statistics
Total Valuation
IDX:CMNP has a market cap or net worth of IDR 7.85 trillion. The enterprise value is 15.21 trillion.
| Market Cap | 7.85T |
| Enterprise Value | 15.21T |
Important Dates
The last earnings date was Thursday, July 31, 2025.
| Earnings Date | Jul 31, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IDX:CMNP has 6.04 billion shares outstanding. The number of shares has increased by 11.25% in one year.
| Current Share Class | 6.04B |
| Shares Outstanding | 6.04B |
| Shares Change (YoY) | +11.25% |
| Shares Change (QoQ) | -2.43% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 60.28% |
| Float | 6.04B |
Valuation Ratios
The trailing PE ratio is 7.88.
| PE Ratio | 7.88 |
| Forward PE | n/a |
| PS Ratio | 1.70 |
| PB Ratio | 0.52 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 7.60 |
| P/OCF Ratio | 7.13 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.64, with an EV/FCF ratio of 14.72.
| EV / Earnings | 15.17 |
| EV / Sales | 3.30 |
| EV / EBITDA | 7.64 |
| EV / EBIT | 8.86 |
| EV / FCF | 14.72 |
Financial Position
The company has a current ratio of 0.94, with a Debt / Equity ratio of 0.43.
| Current Ratio | 0.94 |
| Quick Ratio | 0.50 |
| Debt / Equity | 0.43 |
| Debt / EBITDA | 3.28 |
| Debt / FCF | 6.24 |
| Interest Coverage | 3.06 |
Financial Efficiency
Return on equity (ROE) is 6.24% and return on invested capital (ROIC) is 5.24%.
| Return on Equity (ROE) | 6.24% |
| Return on Assets (ROA) | 4.61% |
| Return on Invested Capital (ROIC) | 5.24% |
| Return on Capital Employed (ROCE) | 7.82% |
| Revenue Per Employee | 20.51B |
| Profits Per Employee | 4.46B |
| Employee Count | 148 |
| Asset Turnover | 0.20 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, IDX:CMNP has paid 359.87 billion in taxes.
| Income Tax | 359.87B |
| Effective Tax Rate | 28.74% |
Stock Price Statistics
The stock price has decreased by -11.82% in the last 52 weeks. The beta is 0.43, so IDX:CMNP's price volatility has been lower than the market average.
| Beta (5Y) | 0.43 |
| 52-Week Price Change | -11.82% |
| 50-Day Moving Average | 1,328.00 |
| 200-Day Moving Average | 1,706.68 |
| Relative Strength Index (RSI) | 43.40 |
| Average Volume (20 Days) | 309,375 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IDX:CMNP had revenue of IDR 4.61 trillion and earned 1.00 trillion in profits. Earnings per share was 164.89.
| Revenue | 4.61T |
| Gross Profit | 1.93T |
| Operating Income | 1.69T |
| Pretax Income | 1.25T |
| Net Income | 1.00T |
| EBITDA | 1.97T |
| EBIT | 1.69T |
| Earnings Per Share (EPS) | 164.89 |
Balance Sheet
The company has 502.45 billion in cash and 6.45 trillion in debt, giving a net cash position of -5,948.82 billion or -984.97 per share.
| Cash & Cash Equivalents | 502.45B |
| Total Debt | 6.45T |
| Net Cash | -5,948.82B |
| Net Cash Per Share | -984.97 |
| Equity (Book Value) | 15.05T |
| Book Value Per Share | 2,257.60 |
| Working Capital | -145.88B |
Cash Flow
In the last 12 months, operating cash flow was 1.10 trillion and capital expenditures -67.54 billion, giving a free cash flow of 1.03 trillion.
| Operating Cash Flow | 1.10T |
| Capital Expenditures | -67.54B |
| Free Cash Flow | 1.03T |
| FCF Per Share | 171.08 |
Margins
Gross margin is 41.77%, with operating and profit margins of 36.69% and 21.73%.
| Gross Margin | 41.77% |
| Operating Margin | 36.69% |
| Pretax Margin | 27.13% |
| Profit Margin | 21.73% |
| EBITDA Margin | 42.65% |
| EBIT Margin | 36.69% |
| FCF Margin | 22.39% |
Dividends & Yields
IDX:CMNP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.25% |
| Shareholder Yield | n/a |
| Earnings Yield | 12.77% |
| FCF Yield | 13.16% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on January 11, 2017. It was a forward split with a ratio of 1.2222222.
| Last Split Date | Jan 11, 2017 |
| Split Type | Forward |
| Split Ratio | 1.2222222 |
Scores
IDX:CMNP has an Altman Z-Score of 1.49 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.49 |
| Piotroski F-Score | 6 |